62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England (2017)

First Author: Yip K

Attributed to: Ensuring test evaluation research is applicable in practice: investigating the effects of routine data on the validity of test accuracy meta-analyses funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Lung Cancer